Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to $162834.0.

  • Cardio Diagnostics Holdings' Capital Expenditures rose 60048.18% to $162834.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $190955.0, marking a year-over-year decrease of 7447.74%. This contributed to the annual value of $214765.0 for FY2024, which is 6269.26% down from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Capital Expenditures stood at $162834.0, which was up 60048.18% from $18696.0 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Capital Expenditures' 5-year high stood at $537053.0 during Q4 2023, with a 5-year trough of -$256991.0 in Q2 2023.
  • Its 4-year average for Capital Expenditures is $97201.6, with a median of $21615.5 in 2024.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 9932.26% in 2024, then skyrocketed by 60048.18% in 2025.
  • Over the past 4 years, Cardio Diagnostics Holdings' Capital Expenditures (Quarter) stood at $188674.0 in 2022, then skyrocketed by 184.65% to $537053.0 in 2023, then crashed by 99.32% to $3638.0 in 2024, then skyrocketed by 4375.92% to $162834.0 in 2025.
  • Its last three reported values are $162834.0 in Q3 2025, $18696.0 for Q2 2025, and $5787.0 during Q1 2025.